US 12286630
Treatment methods for muscular dystrophy
granted A61PA61P21/00
Quick answer
US patent 12286630 (Treatment methods for muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P21/00